Severe cutaneous adverse drug reactions - Relevant aspects to diagnosis and treatment - Part II;Reações cutâneas graves adversas a drogas - Aspectos relevantes ao diagnóstico e ao tratamento - Parte II

Anais Brasileiros de Dermatologia

Volumn 79, Issue 5, 2004, Pages 587-601

  Criado, Paulo Ricardo ^a,c   Ramos, Rodrigo De Oliveira ^a   Criado, Roberta Fachini Jardim ^a   Gonçalves, Andréia Christina ^b   Vasconcellos, Cidia ^a  

^a HOSPITAL DO SERVIDOR PÚBLICO ESTADUAL DE SÃO PAULO   (Brazil)

^b ESTÁCIO DE SÁ UNIVERSITY   (Brazil)

^c USP ^*  (Brazil)

Author keywords

Drug hypersensitivity; Exanthema; Hepatitis, chronic, drug induced; Pharmaceutical preparations adverse effects; Serum sickness; Vasculitis

Indexed keywords

EID: 53549108917     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/S0365-05962004000500010     Document Type: Review

References (33)

1. Roujeau J-C, Stern RS. Severe adverse cutaneous reaction to drugs. N Engl J Med. 1994;10:1272-85.
2. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Sem Cutan Med Surgery. 1996;15:250-7.
3. Criado PR, Lucena SK, Crivellaro APGS, Criado RFJ, Tebcherani A, Nogueira AT et al. Síndrome de hipersensibilidade a anticonvulsivantes: relato de dois casos. Rev Bras Clin Terap. 2002;28:59-63.
4. Kennebeck GA. Anticonvulsant Hypersensitivity Syndrome. J Am Board Fam Pract. 2000;13:364-70.
5. Jonas D, Chhiap V, Resor S, Appel G, Grossman ME. Phenytoin-like hypersensitivity associated with lamotrigine. J Am Acad Dermatol. 1997;36:1016-8.
6. Gupta AK, Kopstein JB, Shear NH. Hypersensitivity reaction to terbinafine. J Am Acad Dermatol. 1997;36:1018-9.
7. Ward HA, Russo GG, Shrum J. Cutaneous manifestations of antiretroviral therapy. J Am Acad Dermatol. 2002;46:284-93.
8. Castell JV. Allergic hepatitis: a drug-mediated organ-specific immune reaction. Clin Exp Allergy. 1998;28:13-9.
9. Shapiro LE, Shear NH. Mecanisms of drug reaction the metabolic track. Sem Cutan Med Surg. 1996;15 :217-27.
10. Hashimoto K, Yasukawa M, Tohyama M. Human herpesvirus 6 and drug allerg y, Curr Opin Allergy Clin Immunol. 2003;3:255-60.
11. Tohyama M, Yahata Y, Yasukawa M et al. Severe hypersensitivity syndrome due to sulfalazine associated with reactivation of human herpesvirus 6. Arch Dermatol. 1998; 134: 1113-7.
12. Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T. Human herpesvirus 6 infection as a risk factor for the development of severe drug induced hypersensitivity syndrome. Arch Dermatol. 1998; 134: 1108-12.
13. Criado PR, Criado RFJ, Vasconcellos C, Pegas JRP, Cera PC. Drug-induced hypersensitivity syndrome due to anticonvulsants in a two-year-old boy. J Dermatol. In press 2004.
14. Carrol MC, Yueng-Yue KA, Esterly NB, Drolet BA. Drug-induced hypersensitivity syndrome in pediatric patients. Pediatrics. 2001;108:485-92.
15. Sidoroff A, Halevy S, Bavinck JNB, Vailant L, Roujeau JC. Acute generalized exanthematous pustulosis (AGEP)- a clinical reaction pattern. J Cutan Pathol. 2001;28:113-19.
16. Young PC, Turiansky GW, Bonner MW, Benson PM. Acute generalized exanthematous pustulosis induced by chromium picolinate. J Am Acad Dermatol. 1999;41:820-3.
17. Galvao C, Criado RFJ, Criado PR, Valente NY, de Mello JF, Fernandes MF. Acute generalized exanthematous pustulosis induced by ingestion of bamifylline. J Eur Acad Dermatol Venereol. 2002;16:634-7.
18. Bristschgi M, Steiner UC, Schmid S, Depta JP, Senti G, Bircher A et al. T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest. 2001;107:1433-41.
19. Bigby M, Stern RS, Arndt KA. Allergic Cutaneous Reactions to Drugs. Primare Care. 1989;16:713-27.
20. Crowson AN, Magro CM. Recents advances in the pathology of cutaneous drug eruptions. Dermatol Clin. 1999;17:537-60.
21. Lotti T, Ghersetich I, Comocchi C, Jorizzo JL. Cutaneous small-vessel vasculitis. J Am Acad Dermatol. 1998;39:667-87.
22. Calabrese LH, Duna GF. Drug-induced vasculitis. Curr Opin Rheumatol. 1996;8:34-40.
23. Leung A C T, McLay A, Dobbie JW, Jones JM. Phenylbutazone-induced systemic vasculitis with crescentic glomerulonephritis. Arch Intern Med. 1985;145:685-7.
24. Rosemberg JL, Edlow D, Sneider R. Liver disease and vasculitis in a patient taking cromolyn. Arch Intern Med. 1978;138:989-91.
25. ten Holder AM, Joy MS, Falk RJ. Cutaneous and systemic manifestations of drug-induced vasculitis. Ann Pharmacother. 2002;36:130-47.
26. Florentino DF. Cutaneous vasculitis. J Am Acad Dermatol. 2003;48:311-40.
27. Chastain MA, Russo GG, Boh EE, Chastain JB, Falabella A, Millikan LE. Propylthiouracil hypersensitivity: report of two patients with vasculitis and review of the literature. J Am Acad Dermatol. 1999;41:757-64.
28. Park KEJ, Chipps DR, Benson EM. Necrotizing vasculitis secondary to propylthiouracil presenting as purpura fulminans. Rheumatology (Oxford) 1999;38:790-2.
29. Gruchalla R. Advances in allergic diseases: An update for the new millennium. Understanding drug allergies. J Allergy Clin Immunol. 2000;105:s637-44.
30. Ghislain P-D, Roujeau J-C. Treatment of severe drug reaction: Stevens-Johnson syndrome, Toxic Epidermal Necrolysis and Hypersensitivity syndrome. Dermatology Online Journal [serial the internete] 2002;8:5. Avaliable from: http://dermatology.cdlib.org/DOJvol8num1/reviews/drugxn/ghislain.html
31. Criado RFJ, Criado PR, Vasconcellos C. Reações cutâneas graves adversas a drogas: definições, sinais de alerta e opções terapêuticas. Rev bras alerg imunopatol. 2003; 26:110-128.
32. Colombel JF, Loftus EV Jr, Tremaine WJ, Egan LJ, Harmsen WS, Schleck CD et al. The safety profile of infliximab in patients with Cronh's disease: the Mayo clinic experience in 500 patients. Gastroenterology. 2004; 126:19-31.
33. Weber RW. Adverse reactions to biological modifiers. Curr Opin Allergy Clin Immunol. 2004; 4: 277-283.